Literature DB >> 431399

Chronic neutropenia.

D C Dale, D Guerry, J R Wewerka, J M Bull, M J Chusid.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 431399     DOI： 10.1097/00005792-197903000-00002

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN： 0025-7974            Impact factor:   1.889


× No keyword cloud information.
  20 in total

1.  Staphylococcus aureus leucocidin ED contributes to systemic infection by targeting neutrophils and promoting bacterial growth in vivo.

Authors:  Francis Alonzo; Meredith A Benson; John Chen; Richard P Novick; Bo Shopsin; Victor J Torres
Journal:  Mol Microbiol       Date:  2011-12-20       Impact factor: 3.501

Review 2.  The molecular pathology of primary immunodeficiencies.

Authors:  Megan S Lim; Kojo S J Elenitoba-Johnson
Journal:  J Mol Diagn       Date:  2004-05       Impact factor: 5.568

Review 3.  Macrophages in resistance to candidiasis.

Authors:  A Vázquez-Torres; E Balish
Journal:  Microbiol Mol Biol Rev       Date:  1997-06       Impact factor: 11.056

Review 4.  The role of neutrophils in the immune system: an overview.

Authors:  Harry L Malech; Frank R Deleo; Mark T Quinn
Journal:  Methods Mol Biol       Date:  2014

Review 5.  An update on the diagnosis and treatment of chronic idiopathic neutropenia.

Authors:  David C Dale; Audrey A Bolyard
Journal:  Curr Opin Hematol       Date:  2017-01       Impact factor: 3.284

6.  Abnormal telomere shortening of peripheral blood mononuclear cells and granulocytes in patients with chronic idiopathic neutropenia.

Authors:  Konstantia I Pavlaki; Maria-Christina Kastrinaki; Michail Klontzas; Maria Velegraki; Irene Mavroudi; Helen A Papadaki
Journal:  Haematologica       Date:  2011-12-01       Impact factor: 9.941

7.  Increased levels of the high mobility group box 1 protein sustain the inflammatory bone marrow microenvironment in patients with chronic idiopathic neutropenia via activation of toll-like receptor 4.

Authors:  Maria Velegraki; Helen Koutala; Christos Tsatsanis; Helen A Papadaki
Journal:  J Clin Immunol       Date:  2011-11-30       Impact factor: 8.317

Review 8.  Recombinant granulocyte colony-stimulating factor (rG-CSF). A review of its pharmacological properties and prospective role in neutropenic conditions.

Authors:  L M Hollingshead; K L Goa
Journal:  Drugs       Date:  1991-08       Impact factor: 9.546

9.  A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia.

Authors:  D C Dale; M A Bonilla; M W Davis; A M Nakanishi; W P Hammond; J Kurtzberg; W Wang; A Jakubowski; E Winton; P Lalezari
Journal:  Blood       Date:  1993-05-15       Impact factor: 22.113

Review 10.  Life-threatening idiosyncratic drug-induced agranulocytosis in elderly patients.

Authors:  Emmanuel Andrès; Esther Noel; Jean-Emmanuel Kurtz; Nourredine Henoun Loukili; Georges Kaltenbach; Frédéric Maloisel
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.